(Total Views: 442)
Posted On: 11/11/2019 9:55:20 PM
Post# of 145903
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Strange PR wording.....
“The treatment of mTNBC with leronlimab in this Phase 1b/2 trial is in addition to metastatic breast cancer (“MBC”) patients treated .”
MBC patients....I thought there was only one?
“The treatment of mTNBC with leronlimab in this Phase 1b/2 trial is in addition to metastatic breast cancer (“MBC”) patients treated .”
MBC patients....I thought there was only one?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)